Neither acute nor chronic exposure to a naturalistic (predator) stressor influences the interleukin-1β system, tumor necrosis factor-α, transforming growth factor-β1, and neuropeptide mRNAs in specific brain regions

被引:65
作者
Plata-Salamán, CR [1 ]
Ilyin, SE
Turrin, NP
Gayle, D
Flynn, MC
Bedard, T
Merali, Z
Anisman, H
机构
[1] Univ Delaware, Sch Life & Hlth Sci, Div Mol Biol, Newark, DE 19716 USA
[2] Univ Ottawa, Sch Psychol, Ottawa, ON K1N 6N5, Canada
[3] Univ Ottawa, Inst Cellular & Mol Med, Ottawa, ON K1N 6N5, Canada
[4] Carleton Univ, Inst Neurosci, Ottawa, ON K1S 5B6, Canada
基金
美国国家卫生研究院; 英国医学研究理事会;
关键词
stress; corticosterone; cytokine; interleukin; receptor antagonist; accessory protein; tumor necrosis factor-alpha; growth factor; neuropeptide Y; glycoprotein; 130; leptin receptor; pro-opiomelanocortin; hypothalamus; cortex; amygdala; hippocampus;
D O I
10.1016/S0361-9230(99)00204-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Physical (neurogenic) stressors may influence immune functioning and interleukin-1 beta (IL-1 beta) mRNA levels within several brain regions. The present study assessed the effects of an acute or repeated naturalistic, psychogenic stressor (predator exposure) on brain cytokine and neuropeptide mRNAs. Acute predator (ferret) exposure induced stress-like behavioral effects, including elicitation of a startle response and reduced exploratory behaviors; these responses diminished after 30 sessions. Moreover, acute and repeated predator exposure, like acute restraint stress, increased plasma corticosterone levels measured 5 min later, but not 2 h after stressor exposure. In contrast, none of the stressors used influenced IL-1 beta, IL-1 receptor antagonist, IL-1 receptor type I, IL-1 receptor accessory proteins I and II, or tumor necrosis factor-alpha mRNA levels in the prefrontal cortex, amygdala, hippocampus, or hypothalamus. Likewise, there were no stressor effects on transforming growth factor-beta 1, neuropeptide Y, glycoprotein 130, or leptin receptor mRNAs in brain regions. Thus, the naturalistic/psychogenic stressor used does not affect any of the brain cytokine component mRNAs studied. It is suggested that this type of stressor activates homeostatic mechanisms (e.g., glucocorticoid release), which act to preclude brain cytokine alterations that would otherwise favor neuroinflammatory/neuroimmunological responses and the consequent increase of brain sensitivity to neurotoxic and neurodegenerative processes. (C) 2000 Elsevier Science Inc.
引用
收藏
页码:187 / 193
页数:7
相关论文
共 42 条
[1]   LASTING EFFECTS ON RODENT ANXIETY OF A SINGLE EXPOSURE TO A CAT [J].
ADAMEC, RE ;
SHALLOW, T .
PHYSIOLOGY & BEHAVIOR, 1993, 54 (01) :101-109
[2]  
Anisman H, 1993, Rev Neurosci, V4, P147
[3]   Influence of psychogenic and neurogenic stressors on endocrine and immune activity: Differential effects in fast and slow seizing rat strains [J].
Anisman, H ;
Lu, ZW ;
Song, C ;
Kent, P ;
McIntyre, DC ;
Merali, Z .
BRAIN BEHAVIOR AND IMMUNITY, 1997, 11 (01) :63-74
[4]  
Anisman H, 1998, Stress, V2, P209
[5]   ANTIPREDATOR DEFENSIVE BEHAVIORS IN A VISIBLE BURROW SYSTEM [J].
BLANCHARD, RJ ;
BLANCHARD, DC .
JOURNAL OF COMPARATIVE PSYCHOLOGY, 1989, 103 (01) :70-82
[6]   Cytokine modulation by glucocorticoids: Mechanisms and actions in cellular studies [J].
Brattsand, R ;
Linden, M .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1996, 10 :81-90
[7]   DISTRIBUTION AND CHARACTERIZATION OF TUMOR NECROSIS FACTOR-ALPHA-LIKE IMMUNOREACTIVITY IN THE MURINE CENTRAL-NERVOUS-SYSTEM [J].
BREDER, CD ;
TSUJIMOTO, M ;
TERANO, Y ;
SCOTT, DW ;
SAPER, CB .
JOURNAL OF COMPARATIVE NEUROLOGY, 1993, 337 (04) :543-567
[8]   PERIPHERAL LIPOPOLYSACCHARIDE STIMULATION INDUCES INTERLEUKIN-1-BETA MESSENGER-RNA IN RAT-BRAIN MICROGLIAL CELLS [J].
BUTTINI, M ;
BODDEKE, H .
NEUROSCIENCE, 1995, 65 (02) :523-530
[9]   CENTRAL ENDOTOXIN INDUCES DIFFERENT PATTERNS OF INTERLEUKIN (IL)-1-BETA AND IL-6 MESSENGER-RIBONUCLEIC-ACID EXPRESSION AND IL-6 SECRETION IN THE BRAIN AND PERIPHERY [J].
DESIMONI, MG ;
DELBO, R ;
DELUIGI, A ;
SIMARD, S ;
FORLONI, G .
ENDOCRINOLOGY, 1995, 136 (03) :897-902
[10]  
GABALLEC MM, 1996, J NEUROIMMUNOL, V66, P65